To support our newly established SFB TRR267, we are offering a
Postdoctoral research position on non-coding cardiovascular RNA
starting at the earliest possible date.
About SFB TRR267
Diseases of the cardiovascular system are the main cause of death worldwide and there is high need for a better understanding of molecular disease mechanisms and improved therapy. Non-coding RNA molecules have come into focus of cardiovascular research, as they control key processes in the cardiovascular system and as successful manipulation in disease models in vivo underscores their therapeutic potential.
To foster research on non-coding RNA in the cardiovascular system, the German Research Foundation DFG has approved funding for a new transregio collaborative research center including five institutions under the leadership of the Technical University of Munich (TUM) and the Goethe University Frankfurt. Over the next four years, the consortium will receive funding of ~10 million €, with the option of continuation.
About the institute
The Institute of Pharmacology and Toxicology is part of the Medical Faculty at the Technical University of Munich (TUM), one of the leading universities in Europe. Our institute takes the lead in a newly established transregio collaborative research center (TRR267), funded by the German Research Foundation DFG. Our research focuses on non-coding RNAs, their control of cardiac gene expression, and the effects of their therapeutic manipulation in cardiac disease. Our team excels in the preparation as well as the targeting of specific cardiac cells in vitro and in vivo. We have a longstanding expertise in the field documented by numerous high-profile publications. To expand further into the analysis of these fascinating RNA molecules, we seek for a motivated postdoctoral fellow to join our group.
- Working in an international team with a strong expertise and motivation and a scientific output of highest quality.
- A state-of-the-art research facility, with mouse phenotyping, human iPS cell programming, flow cytometry, 2photon laser microscopy and laser scanning microscopy (for FRET applications) – to name a few.
- Participation in productive, multidisciplinary interactions with our collaborators, particularly within TRR 267.
- As member of the TUM, you will benefit from programs for early career support and programs to enhance compatibility of family life and career.
The position is available instantly and initially limited to three years, with the option of a longer perspective. Your salary grouping will be according to level TVL-13.
- Highly motivated scientist and commitment to scientific excellence.
- Practical experience in molecular biology, cell culture and, ideally, RNA methodologies.
- Previous work in cardiovascular research is favorable, but not obligatory.
- You have a high degree of responsibility, are independent and enjoy working in a team.
- Flexibility, proactive attitude and interpersonal skills.
- Good communication in English (written and oral).
The TUM aims to substantially increase diversity of its staff. As equal opportunity and affirmative action employer, the TUM explicitly encourages applications from women as well as from all others who would bring additional diversity dimensions to the university’s research and teaching strategies. Preference will be given to disabled candidates with essentially the same qualifications.
Please send your application (cover letter, C.V., recommendations/references, certificates) via email to:
firstname.lastname@example.org. Applications will be considered as they are received and until the position is filled.
Technische Universität München
Institut für Pharmakologie und Toxikologie
Prof. Dr. Dr. Stefan Engelhardt
Biedersteiner Straße 29
Tel. +49 89 4140 3260 email@example.com
Data privacy declaration:
By your recruitment application, you are submitting personalized data to the Technische Universität München (TUM). Please note our Data protection
information for processing personal data in relation to your application. Upon submission of your application, you confirm to have taken notice of this data protection policy.